← Eichor
Study identifier: NCT06792188 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Smartwatch-Based AI Model for OSA Prediction (SWOSA)

Condition: Obstructive Sleep Apnea of Adult · Screening · Smart Watch  ·  Sponsor: Seoul National University Hospital

PhaseN/A
Planned participants147
Who can joinAll sexes, 22 Years to 85 Years
Healthy volunteersNo

About this study

This study aims to develop an artificial intelligence (AI) model for more accurately diagnosing obstructive sleep apnea (OSA) by collecting blood oxygen saturation and other health information during sleep using a smartwatch. OSA is common but often underdiagnosed, and the gold-standard diagnostic test, polysomnography, is costly and time-consuming. Smartwatches can provide a variety of health data, such as sleep patterns, blood oxygen saturation, and heart rate, which can help detect key symptoms and signs of OSA. By developing an AI model that uses smartwatch data to screen for OSA, this study seeks to offer a cost-effective and accessible diagnostic method, ultimately contributing to the early detection and improved treatment rates of OSA.

This description comes directly from the study's public registry record.

Talk to the study team

Jaeyoung Cho, M.D., Ph.D.  ·  +82-2-2072-2503  ·  apricot6@snu.ac.kr

Always discuss trial participation with your own doctor first.

Locations (1)

Seoul National University HospitalSeoul, South KoreaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06792188